Revance Therapeutics Statistics
Total Valuation
RVNC has a market cap or net worth of $383.05 million.
| Market Cap | 383.05M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.69% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1.19 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.12
| Current Ratio | 4.12 |
| Quick Ratio | 2.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.48 |
| Interest Coverage | -8.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.36% |
| Return on Invested Capital (ROIC) | -34.49% |
| Return on Capital Employed (ROCE) | -50.77% |
| Revenue Per Employee | $430,394 |
| Profits Per Employee | -$308,943 |
| Employee Count | 597 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.33 |
Taxes
In the past 12 months, RVNC has paid $1.50 million in taxes.
| Income Tax | 1.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.43% in the last 52 weeks. The beta is 0.95, so RVNC's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -28.43% |
| 50-Day Moving Average | 3.43 |
| 200-Day Moving Average | 4.16 |
| Relative Strength Index (RSI) | 59.52 |
| Average Volume (20 Days) | 2,785,243 |
Short Selling Information
The latest short interest is 4.51 million, so 4.30% of the outstanding shares have been sold short.
| Short Interest | 4.51M |
| Short Previous Month | 8.34M |
| Short % of Shares Out | 4.30% |
| Short % of Float | 4.98% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RVNC had revenue of $256.95 million and -$184.44 million in losses. Loss per share was -$1.91.
| Revenue | 256.95M |
| Gross Profit | 103.69M |
| Operating Income | -193.71M |
| Pretax Income | -301.51M |
| Net Income | -184.44M |
| EBITDA | -187.62M |
| EBIT | -193.71M |
| Loss Per Share | -$1.91 |
Balance Sheet
The company has $184.08 million in cash and $483.45 million in debt, giving a net cash position of -$299.37 million.
| Cash & Cash Equivalents | 184.08M |
| Total Debt | 483.45M |
| Net Cash | -299.37M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -163.03M |
| Book Value Per Share | -1.55 |
| Working Capital | 249.64M |
Cash Flow
In the last 12 months, operating cash flow was -$190.89 million and capital expenditures -$4.02 million, giving a free cash flow of -$194.91 million.
| Operating Cash Flow | -190.89M |
| Capital Expenditures | -4.02M |
| Free Cash Flow | -194.91M |
| FCF Per Share | n/a |
Margins
Gross margin is 40.35%, with operating and profit margins of -75.39% and -71.78%.
| Gross Margin | 40.35% |
| Operating Margin | -75.39% |
| Pretax Margin | -117.35% |
| Profit Margin | -71.78% |
| EBITDA Margin | -73.02% |
| EBIT Margin | -75.39% |
| FCF Margin | n/a |
Dividends & Yields
RVNC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.69% |
| Shareholder Yield | -16.69% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | 113.15% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 20.40% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVNC has an Altman Z-Score of -6.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.36 |
| Piotroski F-Score | 3 |